LVAC logo

LAVA Medtech Acquisition (LVAC) Financials

Balance sheets

Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Apr 30, 2021Mar 1, 2021

Total Assets

$120.7 M(+0.5%)$120.1 M(+0.2%)$119.8 M(-0.1%)$120.0 M-$122.8 K(+30.1%)$94.4 K(+277.6%)$25.0 K-

Current Assets

$1.4 M(-9.5%)$1.5 M(-13.5%)$1.7 M(-6.7%)$1.9 M-----

Non Current Assets

$119.3 M(+0.6%)$118.6 M(+0.4%)$118.1 M(-0.0%)$118.1 M-$122.8 K(+30.1%)$94.4 K(+277.6%)$25.0 K-

Total Liabilities

$4.8 M(-11.1%)$5.4 M(-3.3%)$5.5 M(-25.9%)$7.5 M-$104.0 K(+47.7%)$70.4 K(+6940.0%)$1000.0-

Current Liabilities

$4.8 M(+826.7%)$513.6 K(+77.1%)$290.0 K(+23.8%)$234.3 K-$104.0 K(+47.7%)$70.4 K(+6940.0%)$1000.0-

Long Term Liabilities

$0.0(-100.0%)$4.8 M(-7.8%)$5.3 M(-27.4%)$7.2 M-$0.0(0%)$0.0(0%)$0.0-

Shareholders Equity

$115.9 M(+1.0%)$114.7 M(+0.4%)$114.3 M(+1.6%)$112.5 M-$18.8 K(-21.7%)$24.0 K(0%)$24.0 K-

Book Value

$115.9 M(+1.0%)$114.7 M(+0.4%)$114.3 M(+1.6%)$112.5 M-$18.8 K(-21.7%)$24.0 K(0%)$24.0 K-

Working Capital

-$3.4 M(-440.4%)$996.9 K(-31.6%)$1.5 M(-11.1%)$1.6 M-----

Cash And Cash Equivalents

$1.2 M(+2.6%)$1.1 M(-1.8%)$1.2 M(-13.8%)$1.3 M-----

Accounts Payable

$220.8 K(-36.6%)$348.3 K(+48.1%)$235.2 K(+27.6%)$184.3 K-$6200.0(+520.0%)$1000.0(0%)$1000.0-

Accounts Receivable

---------

Short Term Debt

-----$92.8 K(+70.6%)$54.4 K(+100.0%)$0.0-

Long Term Debt

---------

Total Debt

$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(-100.0%)$92.8 K(+70.6%)$54.4 K(+100.0%)$0.0(0%)$0.0

Debt To Equity

0.0(0%)0.0(0%)0.0(0%)0.0-4.9(+117.6%)2.3(+100.0%)0.0-

Current Ratio

0.3(-90.1%)2.9(-51.2%)6.0(-24.8%)8.0-----

Quick Ratio

---------

Inventory

---------

Retained Earnings

-$3.0 M(+14.0%)-$3.5 M(+2.8%)-$3.6 M(+32.7%)-$5.4 M--$6200.0(-520.0%)-$1000.0(0%)-$1000.0-

PB Ratio

1.3(0%)1.3(+0.8%)1.3(-1.6%)1.3-----

Income statements

Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Apr 30, 2021Mar 1, 2021

EPS

$0.1(+172.0%)$0.0(-75.0%)$0.1(+50.0%)$0.1(-93.6%)$1.3(+312750.0%)-$0.0(-100.0%)$0.0--$0.0

TTM EPS

$0.3(-79.0%)$1.5(+2.1%)$1.5(+9.0%)$1.3(+6.4%)$1.3(+250120.0%)-$0.0(-400.0%)-$0.0--$0.0

Revenue

---------

TTM Revenue

---------

Total Expenses

$378.5 K(-0.8%)$381.6 K(+10.5%)$345.3 K(-24.2%)$455.4 K(+56.3%)$291.3 K(+5501.9%)$5200.0(+100.0%)$0.0-$1000.0

Operating Expenses

$378.5 K(-0.8%)$381.6 K(+10.5%)$345.3 K(-24.2%)$455.4 K(+56.3%)$291.3 K(+5501.9%)$5200.0(+100.0%)$0.0-$1000.0

Cost Of Goods Sold

---------

TTM Cost Of Goods Sold

---------

Gross Profit

---------

TTM Gross Profit

---------

Gross Margin

---------

Operating Profit

-$378.5 K(+0.8%)-$381.6 K(-10.5%)-$345.3 K(+24.2%)-$455.4 K(-56.3%)-$291.3 K(-5501.9%)-$5200.0(-100.0%)$0.0--$1000.0

TTM Operating Profit

-$1.6 M(-5.9%)-$1.5 M(-34.3%)-$1.1 M(-45.9%)-$751.9 K(-152.7%)-$297.5 K(-4698.4%)-$6200.0(-520.0%)-$1000.0--$1000.0

Operating Margin

---------

Net Income

$1.2 M(+154.1%)$461.4 K(-73.7%)$1.8 M(+56.6%)$1.1 M(-93.8%)$18.0 M(+345819.2%)-$5200.0(-100.0%)$0.0--$1000.0

TTM Net Income

$4.5 M(-78.9%)$21.3 M(+2.2%)$20.8 M(+9.2%)$19.1 M(+6.2%)$18.0 M(+289958.1%)-$6200.0(-520.0%)-$1000.0--$1000.0

Net Margin

---------

EBIT

-$378.5 K(+0.8%)-$381.6 K(-10.5%)-$345.3 K(+24.2%)-$455.4 K(-56.3%)-$291.3 K(-5501.9%)-$5200.0(-100.0%)$0.0--$1000.0

TTM EBIT

-$1.6 M(-5.9%)-$1.5 M(-34.3%)-$1.1 M(-45.9%)-$751.9 K(-152.7%)-$297.5 K(-4698.4%)-$6200.0(-520.0%)-$1000.0--$1000.0

EBITDA

-$378.5 K(+0.8%)-$381.6 K(-10.5%)-$345.3 K(+24.2%)-$455.4 K(-56.3%)-$291.3 K(-5501.9%)-$5200.0(-100.0%)$0.0--$1000.0

TTM EBITDA

-$1.6 M(-5.9%)-$1.5 M(-34.3%)-$1.1 M(-45.9%)-$751.9 K(-152.7%)-$297.5 K(-4698.4%)-$6200.0(-520.0%)-$1000.0--$1000.0

Selling, General & Administrative Expenses

$271.1 K(-16.9%)$326.4 K(+8.6%)$300.5 K(-24.9%)$400.2 K(+102.0%)$198.1 K(+3709.6%)$5200.0(+100.0%)$0.0-$1000.0

TTM SGA

$1.3 M(+6.0%)$1.2 M(+35.5%)$904.0 K(+49.8%)$603.5 K(+195.4%)$204.3 K(+3195.2%)$6200.0(+520.0%)$1000.0-$1000.0

Depreciation And Amortization

---------

TTM D&A

---------

Interest Expense

---------

TTM Interest Expense

---------

Income Tax

$188.5 K(+86.6%)$101.0 K(+322.6%)$23.9 K(+362.6%)-$9100.0(+52.6%)-$19.2 K(-100.0%)$0.0(0%)$0.0-$0.0

TTM Income Tax

$304.3 K(+215.0%)$96.6 K(+2295.4%)-$4400.0(+84.5%)-$28.3 K(-47.4%)-$19.2 K(-100.0%)$0.0(0%)$0.0-$0.0

PE Ratio

32.7(+381.6%)6.8(-1.2%)6.9(-8.4%)7.5(-4.8%)7.9----

PS Ratio

---------

Cashflow statements

Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Apr 30, 2021Mar 1, 2021

Cash From Operations

-$950.5 K(-239.2%)$682.7 K(+471.8%)-$183.6 K(+11.5%)-$207.5 K--$0.0-$0.0

TTM CFO

-$658.9 K(-326.0%)$291.6 K(+174.6%)-$391.1 K(-88.5%)-$207.5 K--$0.0-$0.0

Cash From Investing

$979.8 K(+239.3%)-$703.1 K-------

TTM CFI

$276.7 K(+139.3%)-$703.1 K-------

Cash From Financing

---------

TTM CFF

---------

Free Cash Flow

-$950.5 K(-239.2%)$682.7 K(+471.8%)-$183.6 K(+11.5%)-$207.5 K--$0.0-$0.0

TTM FCF

-$658.9 K(-326.0%)$291.6 K(+174.6%)-$391.1 K(-88.5%)-$207.5 K--$0.0-$0.0

CAPEX

---------

TTM CAPEX

---------

Dividends Paid

---------

TTM Dividends Paid

---------

TTM Dividend Per Share

---------

TTM Dividend Yield

---------

Payout Ratio

---------